Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Price
Data
About
JNJ stock price forecast
News
Competitors
Tokenization
Crypto
FAQ
Johnson & Johnson stock logo

Johnson & Johnson

JNJ·NYSE

Last updated as of 2026-02-26 14:40 EST. Stock price information is sourced from TradingView and reflects real-time market prices.

Insights
Calculator
News

JNJ stock price change

On the last trading day, JNJ stock closed at 245.17 USD, with a price change of -0.45% for the day.
Trade stock perps

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more

JNJ key data

Previous close245.17 USD
Market cap590.83B USD
Volume7.61M
P/E ratio22.20
Dividend yield (TTM)2.09%
Dividend amount1.30 USD
Last ex-dividend dateNov 25, 2025
Last payment dateDec 09, 2025
EPS diluted (TTM)11.05 USD
Net income (FY)26.80B USD
Revenue (FY)94.19B USD
Next report dateApr 14, 2026
EPS estimate2.690 USD
Revenue estimate23.60B USD USD
Shares float2.41B
Beta (1Y)0.13
Tokenized stocks

Have you heard of stock tokens?

A new way to trade stocks — anytime, anywhere, 24/7.

Learn more

Johnson & Johnson overview

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
Joaquin Duato
Headquarters
New Brunswick
Website
jnj.com
Founded
1887
Employees (FY)
-
Change (1Y)
-
Revenue / Employee (1Y)
-
Net income / Employee (1Y)
-

JNJ Pulse

Daily updates on JNJ stock prices, fund flows, and market news, generated by AI and reviewed by our team of analysts. Always DYOR.

• JNJ Stock Price 24h change: +0.18%. From 245.84 USD to 246.28 USD. The stock reached a new all-time high, supported by strong oncology sales momentum and its "safe haven" status amid tech sector volatility, despite trading ex-dividend ($1.30).
• From a technical perspective, the stock is in a "strong bullish breakout": JNJ is trading near its 52-week high ($247.25) with a 50-day MA ($222.42) well above the 200-day MA ($200.48). However, an RSI of 70.35 indicates overbought conditions, suggesting a potential short-term consolidation or minor pullback toward support at $242.36.
• Johnson & Johnson sought FDA approval for nipocalimab (IMAAVY) as the first treatment for warm autoimmune hemolytic anemia (wAIHA) following positive pivotal data.
• Bayer filed a lawsuit against J&J and its Janssen unit, alleging false advertising regarding the prostate cancer drug Nubeqa, creating a minor legal overhang for the biotech division.
• J&J is reportedly exploring a sale of its DePuy Synthes orthopaedics unit as part of a strategic shift toward higher-margin MedTech and oncology assets.
• The U.S. Supreme Court struck down several major trade tariffs, a move expected to benefit global pharmaceutical supply chains by reducing costs for imported components and materials.
• Healthcare leaders are shifting from AI experimentation to large-scale deployment, with new reports projecting the global healthcare workforce management market to reach $6.26 billion by 2035.
See more
about 1D ago
• JNJ Stock Price 24h change: +1.38%. From 242.49 USD to 245.84 USD. The price rose as investors cheered strong growth in oncology sales (Carvykti and Darzalex) and a potential $20 billion divestiture of its orthopedics unit.
• From a technical perspective, JNJ exhibits a "Strong Bullish" trend across all timeframes. Moving averages (MA5 to MA200) all signal a "Buy," though an RSI of 73.83 suggests the stock is entering overbought territory, indicating potential for a short-term consolidation after its 11.4% monthly gain.
• Johnson & Johnson is reportedly exploring a sale of its orthopedics unit, DePuy Synthes, for over $20 billion to private equity firms to focus on high-growth pharma and medtech segments.
• J&J announced that TREMFYA demonstrated sustained clinical and endoscopic remission in ulcerative colitis patients through three years of long-term data.
• Bayer filed a lawsuit against J&J alleging false advertising regarding its prostate cancer treatment, creating a potential legal headwind for the oncology division.
• The U.S. Supreme Court ruled 6-3 that the International Emergency Economic Powers Act does not authorize the President to impose broad tariffs, providing temporary relief for pharma supply chains.
• The healthcare sector is seeing a record surge in private equity activity, with 2025 deal values hitting $191 billion, a trend expected to accelerate M&A and consolidation through 2026.
See more
about 2D ago

JNJ stock price forecast

According to technical indicators for JNJ stock, the price is likely to fluctuate within the range of 262.64–306.46 USD over the next week. Market analysts predict that the price of JNJ stock will likely fluctuate within the range of 246.16–325.05 USD over the next months.

Based on 1-year price forecasts from 89 analysts, the highest estimate is 567.44 USD, while the lowest estimate is 250.84 USD.

For more information, please see the JNJ stock price forecast page.

Latest JNJ stock news

Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results

Finviz2026-02-24 13:06:44

Healthcare Industry Poised for Growth in 2026: Key Insights for Investors

101 finance2026-02-25 12:27:55

Healthcare Industry Poised for Growth in 2026: Key Insights for Investors

101 finance2026-02-25 12:27:55

Top Robotics Shares to Consider Investing in Now for Strong Profits

101 finance2026-02-25 14:27:54

Is Johnson & Johnson Able to Maintain Its Strong Double-Digit Growth in Oncology?

101 finance2026-02-25 14:57:58

Goldman Sachs Lifts Honeywell (HON) Price Target Following Re-Segmentation Update

Finviz2026-02-25 15:36:39

Why Is Lumen Technologies Stock Gaining Wednesday?

Finviz2026-02-25 15:42:44

Liquidia Shares Fall 10.5%: Unpacking the Reasons for the Steep Decline

101 finance2026-02-25 16:46:37

Are you searching for a dividend stock with strong growth potential?

101 finance2026-02-25 17:48:40

TopBuild Grows Presence in Texas Through Acquisition of Johnson Roofing

101 finance2026-02-25 18:15:44

Johnson & Johnson's 0.45% Mysterious Slide Without Clear Catalyst Despite 54th-Ranked $1.87B Volume

101 finance2026-02-25 22:33:36

Honeywell Tumbles 0.58% Amid Revised Johnson Matthey Deal as 810M Volume Ranks 157th

101 finance2026-02-25 23:09:47

Morgan Stanley forecasts that artificial intelligence won't enable early retirement; rather, you'll need to prepare for careers that have not yet been created

101 finance2026-02-26 11:00:51

Jim Cramer on Caterpillar: "We Like Their Stuff"

Finviz2026-02-26 15:00:16

3 Leading Technology Mutual Funds to Enhance Your Portfolio's Long-Term Growth

101 finance2026-02-26 15:13:12

With just a Bitget account, you can trade stocks and cryptocurrencies at the same time.

Join now!

FAQ

What is the stock price of Johnson & Johnson?

JNJ is currently priced at 245.17 USD — its price has changed by -0.45% over the past 24 hours. You can track the stock price performance of Johnson & Johnson more closely on the price chart at the top of this page.

What is the stock ticker of Johnson & Johnson?

Depending on the exchange, the stock ticker may vary. For instance, on NYSE, Johnson & Johnson is traded under the ticker JNJ.

What is the stock forecast of JNJ?

We've gathered analysts' opinions on Johnson & Johnson's future price. According to their forecasts, JNJ has a maximum estimate of 2451.70 USD and a minimum estimate of 490.34 USD.

What is the market cap of Johnson & Johnson?

Johnson & Johnson has a market capitalization of 590.83B USD.

What is P/E ratio (TTM)?

The P/E ratio (TTM) stands for price-to-earnings ratio (trailing twelve months). It is a historical valuation metric calculated using a company's earnings per share (EPS) over the most recent twelve consecutive months, reflecting the company's past profitability.

The P/E ratio measures the relationship between a stock's price and a company's profitability, and is often used as a basis for judging whether a stock is "cheap" or "expensive."

P/E ratio = market price (P) ÷ earnings per share (EPS), or P/E ratio = total market capitalization ÷ net profit attributable to shareholders

The interpretation of the P/E ratio (TTM) should always be considered alongside other factors and is mainly used for valuation comparisons rather than as a standalone indicator.

  • A lower P/E ratio (TTM) means investors are paying less for each unit of earnings. This may indicate that the stock is undervalued, or that the market has limited expectations for the company's future growth, such as in mature or slow-growing industries.
  • A higher P/E ratio (TTM) means investors are paying more for each unit of earnings. This often reflects expectations of strong future earnings growth, which is common among growth or technology stocks, though it may also suggest the stock is overvalued.
  • Comparison with peers: Compare the company's P/E (TTM) with the average or median P/E of other companies in the same industry. A significantly higher P/E may require further analysis to determine whether the company's high valuation is justified by stronger growth prospects or competitive advantages.
  • Comparison with historical levels: Compare the company's current P/E (TTM) with its own historical average (such as over the past 5 or 10 years) to assess whether the current valuation is at a historical high or low.
  • Comparison with the broader market: Compare the company's P/E (TTM) with major market indices (such as the S&P 500) to see how the market is valuing the company overall.

P/E ratios can vary widely across industries, and there is no single "ideal" P/E level. A reasonable P/E range depends on the industry, the company's growth potential, and the broader macroeconomic environment. Investment decisions should not rely solely on the P/E ratio (TTM) but should be based on a comprehensive analysis that includes company quality, growth prospects, and financial health.

Can I trade stocks on Bitget?

You can trade stocks on Bitget, but mainly through stock tokens and stock perps, rather than by directly buying or selling traditional stocks.

This approach reflects Bitget's vision as a Universal Exchange (UEX), designed to connect traditional financial markets with cryptocurrency markets.

Bitget currently offers the following stock-related trading formats:

1. Stock tokens (spot)

Nature: Stock tokens are digital tokens pegged to the price of specific traditional stocks (such as TSLAUSDT and NVDAUSDT) and are traded on Bitget's spot market.

Features: When you trade stock tokens, you are buying and holding tokens rather than owning the underlying traditional stocks.

  • The price of these tokens generally follows the price movements of the stocks they are pegged to, such as Tesla or Nvidia.
  • The advantage is that you can participate in the price movements of traditional financial assets, such as U.S. stocks, using cryptocurrencies (for example, USDT), without the need for a traditional brokerage account.

2. Stock perps

Nature: Bitget also offers USDT-margined perpetual futures, commonly referred to as stock perps, based on major U.S. blue-chip stocks such as Tesla and Meta.

Characteristics: Stock perps are derivative products that allow you to take a bullish or bearish view on the future price of an underlying stock through margin trading. These products typically support leverage, such as up to 25x.

It does not involve owning the underlying stock. Instead, profits and losses are settled based on price movements of the futures.

Important note: When trading stock perps on Bitget, you are participating in derivative markets within the cryptocurrency ecosystem. This is fundamentally different from purchasing publicly traded shares through a traditional brokerage, as you do not own equity in the underlying company.

Futures trading and the use of leverage involve high risk. Please ensure you fully understand the risks before trading.

If you wish to directly hold equity in traditional stocks and enjoy shareholder rights (such as receiving dividends), you must trade through a regulated traditional securities brokerage or brokerage platform.

What are the advantages of Bitget's stock perps?

Bitget's stock perps—typically perpetual futures based on stock token prices—are an innovative offering that allows cryptocurrency platforms to provide exposure to traditional financial markets.

Compared to traditional stock or futures trading, they offer several unique advantages, primarily due to the platform's trading infrastructure.

Bitget's stock perps, typically USDT-denominated derivatives, offer the following key advantages:

1. Trading convenience and global accessibility

  • 24/7 trading: Traditional stock markets, such as U.S. equity markets, operate during fixed trading hours. In contrast, cryptocurrency derivatives markets are typically open 24/7. This means investors can trade anytime, capitalizing on breaking news or market fluctuations.
  • Lower entry barriers and faster onboarding: Compared with traditional brokerages, which often require extensive identity verification and lengthy account setup processes, Bitget generally offers faster account onboarding. Users can trade using cryptocurrencies such as USDT, without the need for complex fiat deposit and withdrawal procedures.
  • Global accessibility: Users can access derivatives trading linked to globally recognized stocks via the Bitget platform, subject to applicable regulations.

2. Capital efficiency and high leverage

  • High leverage options: Stock perps typically offer higher leverage than traditional stock trading (for example, up to 25x). This allows traders to control larger positions with smaller margin requirements, improving capital efficiency.
    Note: While high leverage can amplify gains, it also amplifies losses proportionally.
  • Two-way trading: Traders can easily take both long and short positions. This means traders can potentially profit from market volatility whether stock prices rise or fall, provided the market direction is correctly anticipated.

3. Trading and settlement using cryptocurrency

  • USDT margin: Stock perps on Bitget typically use USDT (or other stablecoins) as the margin and settlement currency. For users who already hold cryptocurrency, there is no need to convert assets into fiat currency, allowing them to trade directly with stablecoins.
  • Efficient fund transfers: Crypto-based transfers and settlements are typically faster than traditional fiat systems, enabling more efficient global fund allocation.

4. Integration

One-stop platform: Bitget allows users to trade spot cryptocurrencies, crypto derivatives, and stock perps on a single platform, making it easier to manage different asset types in one place.

Risk warning:

While Bitget's stock perps offer several advantages, it is important to understand the associated risks.

  • High leverage risk: Leveraged trading can result in rapid loss of your entire margin.
  • No equity ownership: When trading stock perps, you do not own the underlying shares. As a result, you are not entitled to dividends or voting rights.
  • Market liquidity risk: Stock token perps may have lower liquidity than their counterparts in traditional stock markets, especially outside regular trading hours.

In summary, Bitget's stock perps offer advantages such as greater trading flexibility, lower entry barriers, and higher capital efficiency.

What are the trading fees for Bitget stock perps?

Trading fees for Bitget stock perps (USDT-margined perpetual futures) mainly include transaction fees and funding rates.

Transaction fees:

Bitget offers limited-time fee promotions for stock perps (especially stock token perps) from time to time to attract traders.

Standard reference rates: Under Bitget's standard futures fee structure, the taker fee is typically around 0.06%, while the maker fee is around 0.02%.

Current promotions for stock perps (important): To promote its stock perps products, Bitget is offering discounted transaction fees during Q4 2025, with taker fees as low as 0.006% and maker fees as low as 0.002%. There is also a limited-time promotion offering zero-fee trading for spot stock tokens.

Recommendation: Since promotional activities are subject to change or end at any time, please visit Bitget's official Fee overview or Announcement Center page for the latest and most accurate rates at the time of trading.

Funding rate:

The funding rate is a key mechanism in perpetual futures (including stock perps) that helps keep the futures price closely aligned with the spot price of the underlying asset. It is not a fee charged by the platform, but a periodic payment exchanged between long and short traders.

Funding rates fluctuate dynamically and are mainly driven by market sentiment and imbalances between long and short positions. Stock perps generally experience lower volatility than cryptocurrencies, so funding rates are often relatively low during stable market conditions. However, during earnings seasons or major positive or negative news events, heavy concentration of long or short positions—such as in high-growth technology stocks like Tesla or Nvidia—can create significant imbalances, causing funding rates to spike in the short term.

Funding payments are typically settled every 8 hours. If you close your position before the funding settlement time, no funding payment will be charged or received.

Funding rates are not fixed. If you hold a position for an extended period, high positive funding rates (for long positions) or high negative funding rates (for short positions) will affect your overall holding costs or potential returns. For this reason, it is important to monitor the funding rate in real time on the trading interface.

NYSE/
JNJ